Abstract
Objective:
The aim of this study was to determine if the fat accumulation in the exocrine pancreas fat of obese Zucker diabetic fatty (ZDF) rodents, like that in their endocrine pancreas, precedes the onset of type 2 diabetes mellitus (T2DM). As the fat content of whole pancreas, but not islets, can now be measured in humans by magnetic resonance spectroscopy (MRS), such measurements could be used as a predictor of impending T2DM and an indication for preventive intervention.
Animals:
Obese ZDF (fa/fa) rats and lean (+/+) controls on a 6% fat diet were killed at time points from 6 to 16 weeks and total pancreatic fat was measured biochemically and electronmicroscopic examination of tissue for fat droplets was carried out.
Results:
Compared to lean ZDF controls, pancreatic fat was elevated above lean controls from 6 to 16 weeks of age, peaking at 10 weeks of age when hyperglycemia first appeared. The pancreatic profile of fat content in whole pancreas paralleled that of islets. Electronmicroscopic examination identified the acinar location of the fat droplets and ruled out a major contribution of intrapancreatic adipocytes.
Conclusion:
The almost identical pattern of triglyceride overaccumulation in the exocrine and endocrine pancreas of obese rodents before the onset of T2DM suggests that MRS of the human pancreas might predict T2DM in obese subjects and permit timely interventions to prevent the disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS . Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2008; 18: 222–229.
McGarry JD . Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7–18.
Milburn Jr JL, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995; 270: 1295–1299.
Virtue S, Vidal-Puig A . It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008; 6: e237.
Savage DB, Petersen KF, Shulman GI . Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87: 507–520.
Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH . Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 1998; 273: 32487–32490.
Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH . Protection again lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 1998; 95: 9558–9561.
Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 2008; 49: 2101–2112.
Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH . Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994; 91: 10878–10882.
Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH . Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 1996; 271: 5633–5637.
Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 2002; 51: 1825–1833.
Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007; 30: 2916–2921.
Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009; 94: 4070–4076.
Folch J, Lees M, Sloane Stanley GH . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497–509.
Koyama K, Chen G, Lee Y, Unger RH . Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 1997; 273: E708–E713.
Unger RH, Orci L . Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001; 15: 312–321.
Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA . Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008; 16: 522–530.
Shimabukuro M, Zhou YT, Lee Y, Unger RH . Troglizatone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 1998; 273: 3547–3550.
Hays NP, Galassetti PR, Coker RH . Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther 2008; 118: 181–191.
Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001; 276: 5629–5635.
Ohneda M, Inman LR, Unger RH . Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 1995; 38: 173–179.
Yu X, McCorkle S, Wang M, Lee Y, Li J, Saha AK et al. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipic deposition. Diabetologia 2004; 47: 2012–2021.
Sreenan S, Sturis J, Pugh W, Burant CF, Polonsky KS . Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol 1996; 271: E742–E747.
Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH . Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 1999; 96: 11513–11518.
Unger RH . Reinventing type 2 diabetes: pathogenesis, treatment, and prevention. JAMA 2008; 299: 1185–1187.
Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 382–393.
Liberopoulos EN, Mikhailidis DP, Elisaf MS . Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005; 6: 283–296.
Acknowledgements
We thank the Pole Facultaire de Microscopie Ultrastructurale and the Service Facultaire d’Histologie of Geneva Medical School who kindly provided access to microscopy equipment. Part of this work was financially supported by NIH CTSA Grant UL1 RR024982. ILL was supported by a Doris Duke Charitable Foundation clinical research fellowship. LSS was supported by NIH K25 HL-68736. YL and RHU were supported by NIH Grant R01 DK002700 and the Department of Veterans Affairs Merit Review. LO was supported by the Swiss National Science Foundation. S Kay McCorkle and Peggy McCravy prepared the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, Y., Lingvay, I., Szczepaniak, L. et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes 34, 396–400 (2010). https://doi.org/10.1038/ijo.2009.245
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2009.245
Keywords
This article is cited by
-
Intra-pancreatic fat deposition: bringing hidden fat to the fore
Nature Reviews Gastroenterology & Hepatology (2022)
-
Reducing the risk of postoperative pancreatic fistula in radical gastrectomy: pre-assessment with computed tomography for the diagnosis of pancreatic steatosis
Langenbeck's Archives of Surgery (2022)
-
Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
Diabetology & Metabolic Syndrome (2021)
-
DGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis
Acta Pharmacologica Sinica (2021)
-
Role of aquaporin-7 in ghrelin- and GLP-1-induced improvement of pancreatic β-cell function after sleeve gastrectomy in obese rats
International Journal of Obesity (2017)